Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia. - Yang, Tingting; Dong, Yetian; Zhang, Mingming; Feng, Jingjing; Fu, Shan; Xiao, Pingnan; Hong, Ruimin; Xu, Huijun; Cui, Jiazhen; Huang, Simao; Wei, Guoqing; Kong, Delin; et al. (Experimental Hematology & Oncology, 2025)